415 related articles for article (PubMed ID: 25798913)
1. Formulation and in vitro evaluation of ketoprofen fast-dissolving tablets.
Comoglu T; Inal O; Yaacoub HB
Pharm Dev Technol; 2016 Dec; 21(8):901-908. PubMed ID: 25798913
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
3. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
Sheshala R; Khan N; Darwis Y
Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
[TBL] [Abstract][Full Text] [Related]
4. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of an orally fast disintegrating tablet formulation containing a hydrophobic drug.
Comoglu T; Unal B
Pharm Dev Technol; 2015 Jan; 20(1):60-4. PubMed ID: 24295202
[TBL] [Abstract][Full Text] [Related]
6. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion.
Gryczke A; Schminke S; Maniruzzaman M; Beck J; Douroumis D
Colloids Surf B Biointerfaces; 2011 Sep; 86(2):275-84. PubMed ID: 21592751
[TBL] [Abstract][Full Text] [Related]
8. A pharmaceutical study on lornoxicam fast disintegrating tablets: formulation and in vitro and in vivo evaluation.
Moutasim MY; ElMeshad AN; El-Nabarawi MA
Drug Deliv Transl Res; 2017 Jun; 7(3):450-459. PubMed ID: 28283842
[TBL] [Abstract][Full Text] [Related]
9. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
Cantor SL; Khan MA; Gupta A
Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
[TBL] [Abstract][Full Text] [Related]
10. Novel taste-masked orally disintegrating tablets for a highly soluble drug with an extremely bitter taste: design rationale and evaluation.
Tan Q; Zhang L; Liu G; He D; Yin H; Wang H; Wu J; Liao H; Zhang J
Drug Dev Ind Pharm; 2013 Sep; 39(9):1364-71. PubMed ID: 22994163
[TBL] [Abstract][Full Text] [Related]
11. Preparation and Evaluation of Hot-Melt Extruded Patient-Centric Ketoprofen Mini-Tablets.
Alshetaili AS; Almutairy BK; Tiwari RV; Morott JT; Alshehri SM; Feng X; Alsulays BB; Park JB; Zhang F; Repka MA
Curr Drug Deliv; 2016; 13(5):730-41. PubMed ID: 26456211
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N
Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.
Douroumis DD; Gryczke A; Schminke S
AAPS PharmSciTech; 2011 Mar; 12(1):141-51. PubMed ID: 21181510
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
Devireddy SR; Gonugunta CS; Veerareddy PR
PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
[TBL] [Abstract][Full Text] [Related]
15. Combination effect of physical and gustatory taste masking for propiverine hydrochloride orally disintegrating tablets on palatability.
Matsui R; Uchida S; Namiki N
Biol Pharm Bull; 2015; 38(1):17-22. PubMed ID: 25744453
[TBL] [Abstract][Full Text] [Related]
16. Orally disintegrating systems: innovations in formulation and technology.
Goel H; Rai P; Rana V; Tiwary AK
Recent Pat Drug Deliv Formul; 2008; 2(3):258-74. PubMed ID: 19075912
[TBL] [Abstract][Full Text] [Related]
17. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.
Sheshala R; Khan N; Chitneni M; Darwis Y
Arch Pharm Res; 2011 Nov; 34(11):1945-56. PubMed ID: 22139694
[TBL] [Abstract][Full Text] [Related]
18. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
19. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies.
Fu Y; Yang S; Jeong SH; Kimura S; Park K
Crit Rev Ther Drug Carrier Syst; 2004; 21(6):433-76. PubMed ID: 15658933
[TBL] [Abstract][Full Text] [Related]
20. Novel approach of aceclofenac fast dissolving tablet.
Dave V; Yadav S; Sharma S; Vishwakarma P; Ali N
Pak J Pharm Sci; 2015 Jan; 28(1):37-41. PubMed ID: 25553683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
